MY148300A - Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative - Google Patents
Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivativeInfo
- Publication number
- MY148300A MY148300A MYPI20072165A MY148300A MY 148300 A MY148300 A MY 148300A MY PI20072165 A MYPI20072165 A MY PI20072165A MY 148300 A MY148300 A MY 148300A
- Authority
- MY
- Malaysia
- Prior art keywords
- pyrazolopyrimidinone derivative
- prevention
- treatment
- liver diseases
- present
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO THE PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE AS AN ACTIVE INGREDIENT. ACCORDING TO THE PRESENT INVENTION, PYRAZOLOPYRIMIDINONE DERIVATIVE HAS AN EXCELLENT EFFECT ON INHIBITING COLLAGEN SYNTHESIS IN HEPATIC STELLATE CELLS AND ACTS DIRECTLY ON THE PORTAL VEIN. PARTICULARLY, IT MAY INCREASE THE DIAMETER AND THE AMOUNT OF BLOOD FLOW OF THE PORTAL VEIN, AND FINALLY DECREASE THE PRESSURE THEREOF. THEREFORE, PYRAZOLOPYRIMIDINONE DERIVATIVE CAN BE USED ADVANTAGEOUSLY FOR PREVENTION AND TREATMENT OF HEPATIC FIBROSIS, LIVER CIRRHOSIS CAUSED BY HEPATIC FIBROSIS, PORTAL HYPERTENSION AND VARIOUS COMPLICATIONS CAUSED BY PORTAL HYPERTENSION. IN ADDITION, PYRAZOLOPYRIMIDINONE DERIVATIVE ACCORDING TO THE PRESENT INVENTION CAN REDUCE DOSING FREQUENCY BECAUSE OF ITS LONG HALF-LIFE, AND THEREFORE, HAS AN ADVANTAGE TO IMPROVE THE DRUG COMPLIANCE OF PATIENTS SUFFERING FROM CHRONICAL LIVER DISEASES.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20072165 MY148300A (en) | 2007-12-04 | 2007-12-04 | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20072165 MY148300A (en) | 2007-12-04 | 2007-12-04 | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
MY148300A true MY148300A (en) | 2013-03-29 |
Family
ID=50276841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20072165 MY148300A (en) | 2007-12-04 | 2007-12-04 | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY148300A (en) |
-
2007
- 2007-12-04 MY MYPI20072165 patent/MY148300A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1119596A1 (en) | Use of yrazolopyrimidinone derivative in the preparation of agent for the prevention and treatment of liver diseases | |
AU2018253620A1 (en) | Injectable botulinum toxin formulations | |
EA200870216A1 (en) | AMIDO COMPOUNDS AND THEIR APPLICATION AS MEDICINES | |
EP2349279A4 (en) | Modulators of aldehyde dehydrogenase and methods of use thereof | |
TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
NO20075136L (en) | New liposome preparations | |
DE602006014990D1 (en) | INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN | |
ATE470443T1 (en) | INDOL-1-YL ACID DERIVATIVES | |
NZ588913A (en) | Liver cancer drug | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
MX2009011900A (en) | Diabetic wound healing. | |
TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
MY163762A (en) | Therapeutic agent for chronic renal failure | |
MX2009005798A (en) | Stroke recovery. | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
WO2010044097A3 (en) | Novel dosage form of paliperidone and process for preparing the same | |
WO2009120885A3 (en) | Stabilizing lipid compositions for oral pharmaceutical agents | |
WO2008114376A1 (en) | Melanogenesis inhibitory composition | |
IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
UY30126A1 (en) | A NEW PHARMACEUTICALLY ACCEPTABLE SALT OF 2-HIDROXI-3- (5- (MORFOLIN-4-ILMETIL) -PIRIDIN-2-L) 1H-INDOL-5-CARBONITRILE, PROCEDURES FOR THE PREPARATION, COMPOSITIONS CONTAINING IT AND APPLICATIONS | |
MY148300A (en) | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative | |
WO2009043577A3 (en) | Contraceptive 19-nor progesterones | |
TW200738703A (en) | 2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
WO2008005806A3 (en) | Therapeutic methods, compositions, and compounds |